These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9351766)

  • 1. Illicit use of clonidine in opiate-abusing pregnant women.
    Anderson F; Paluzzi P; Lee J; Huggins G; Svikis D
    Obstet Gynecol; 1997 Nov; 90(5):790-4. PubMed ID: 9351766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimates of illicit drug use during pregnancy by maternal interview, hair analysis, and meconium analysis.
    Ostrea EM; Knapp DK; Tannenbaum L; Ostrea AR; Romero A; Salari V; Ager J
    J Pediatr; 2001 Mar; 138(3):344-8. PubMed ID: 11241040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychosocial risk factors associated with cocaine use during pregnancy: a case-control study.
    Hutchins E; DiPietro J
    Obstet Gynecol; 1997 Jul; 90(1):142-7. PubMed ID: 9207829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychopathology in pregnant drug-dependent women with and without comorbid alcohol dependence.
    Miles DR; Svikis DS; Kulstad And JL; Haug NA
    Alcohol Clin Exp Res; 2001 Jul; 25(7):1012-7. PubMed ID: 11505026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methadone maintenance program in a Swiss perinatal center: (I): Management and outcome of 89 pregnancies.
    Kashiwagi M; Arlettaz R; Lauper U; Zimmermann R; Hebisch G
    Acta Obstet Gynecol Scand; 2005 Feb; 84(2):140-4. PubMed ID: 15683373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Community-wide estimation of illicit drug use in delivering women: prevalence, demographics, and associated risk factors.
    Vaughn AJ; Carzoli RP; Sanchez-Ramos L; Murphy S; Khan N; Chiu T
    Obstet Gynecol; 1993 Jul; 82(1):92-6. PubMed ID: 8515933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial.
    Marsch LA; Bickel WK; Badger GJ; Stothart ME; Quesnel KJ; Stanger C; Brooklyn J
    Arch Gen Psychiatry; 2005 Oct; 62(10):1157-64. PubMed ID: 16203961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tobacco use for identifying pregnant women at risk of substance abuse.
    Svikis D; Henningfield J; Gazaway P; Huggins G; Sosnow K; Hranicka J; Harrow C; Pickens R
    J Reprod Med; 1997 May; 42(5):299-302. PubMed ID: 9172121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smoking and illicit drug use during pregnancy: impact on neonatal outcome.
    Miles DR; Lanni S; Jansson L; Svikis D
    J Reprod Med; 2006 Jul; 51(7):567-72. PubMed ID: 16913548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overview: medications development for the treatment of drug abuse.
    Vocci F; Chiang CN; Cummings L; Hawks R
    NIDA Res Monogr; 1995; 149():4-15. PubMed ID: 8775832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevalence of substance abuse among pregnant women in Utah.
    Buchi KF; Varner MW; Chase RA
    Obstet Gynecol; 1993 Feb; 81(2):239-42. PubMed ID: 8423958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of substance abuse during pregnancy and infant outcome.
    Little BB; Snell LM; Van Beveren TT; Crowell RB; Trayler S; Johnston WL
    Am J Perinatol; 2003 Jul; 20(5):255-62. PubMed ID: 13680509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Problem drinking in relation to treatment outcome among opiate addicts in methadone maintenance treatment.
    Stenbacka M; Beck O; Leifman A; Romelsjö A; Helander A
    Drug Alcohol Rev; 2007 Jan; 26(1):55-63. PubMed ID: 17364837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Universal screening for substance abuse at the time of parturition.
    Azadi A; Dildy GA
    Am J Obstet Gynecol; 2008 May; 198(5):e30-2. PubMed ID: 18279831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contextual differences in substance use for rural Appalachian treatment-seeking women.
    Shannon LM; Havens JR; Mateyoke-Scrivner A; Walker R
    Am J Drug Alcohol Abuse; 2009; 35(2):59-62. PubMed ID: 19199165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying pregnant women at risk for early attrition from substance abuse treatment.
    Kissin WB; Svikis DS; Moylan P; Haug NA; Stitzer ML
    J Subst Abuse Treat; 2004 Jul; 27(1):31-8. PubMed ID: 15223091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensity of opiate withdrawal in relation to the 825C>T polymorphism of the G-protein beta 3 subunit gene.
    Lieb B; Bonnet U; Specka M; Augener S; Bachmann HS; Siffert W; Scherbaum N
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Jun; 33(4):663-7. PubMed ID: 19303909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clonidine--potential dependence risk in psychiatric patients?].
    Agelink MW; Dammers S; Zeit T
    Nervenarzt; 1996 Mar; 67(3):253-5. PubMed ID: 8901285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hospitalizations with amphetamine abuse among pregnant women.
    Cox S; Posner SF; Kourtis AP; Jamieson DJ
    Obstet Gynecol; 2008 Feb; 111(2 Pt 1):341-7. PubMed ID: 18238971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multimodal drug addiction treatment: a field comparison of methadone and buprenorphine among heroin- and cocaine-dependent patients.
    Vigezzi P; Guglielmino L; Marzorati P; Silenzio R; De Chiara M; Corrado F; Cocchi L; Cozzolino E
    J Subst Abuse Treat; 2006 Jul; 31(1):3-7. PubMed ID: 16814005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.